Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|May 22, 2020
The Role of Immunotherapy in Non-transplant Eligible Multiple MyelomaArthur Bobin, Hélène Gardeney, Florence Sabirou, et al.Cancers|October 23, 2021
Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review ArticleArthur Bobin, Cécile Gruchet, Stéphanie Guidez, et al.Journal of Clinical Medicine|November 7, 2020
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma PatientsHélène Gardeney, Arthur Bobin, Cécile Gruchet, et al.Leukemia & Lymphoma|October 21, 2021
Smoldering multiple myeloma: biology, clinical manifestations and managementLaly Nsiala, Arthur Bobin, Anthony Levy, et al.Cancers|October 14, 2020
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020Arthur Bobin, Evelyne Liuu, Niels Moya, et al.Blood Advances|September 21, 2022
Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazineAntoine Machet, Caroline Poudou, Cécile Tomowiak, et al.Leukemia & Lymphoma|June 4, 2021
Waldenström macroglobulinemia and relationship to immune deficiencyAnthony Levy, Stéphanie Guidez, Céline Debiais, et al.Clinical Case Reports|May 19, 2023
Hairy cell leukemia with isolated bone lesionsLaura Cailly, Cécile Gruchet, Elsa Maitre, et al.Oncotarget|May 31, 2018
Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myelomaGuillemette Fouquet, Stéphanie Guidez, Valentine Richez, et al.Cancer Medicine|May 31, 2019
Response to pneumococcal vaccination in multiple myelomaLoïc Renaud, Susanna Schraen, Guillemette Fouquet, et al.Pageof 2